Publications

Journals

• Druce MR; Kaltsas GA; Fraenkel M; Gross DJ; Grossman AB. (1 Sep 2009). Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001). HORMONE AND METABOLIC RESEARCH. 41:697-702. Author weblink DOI.
• Druce MR; Minnion JS; Field BCT; Patel SR; Shillito JC; Tilby M; Beale KEL; Murphy KG; et alGhatei MA; Bloom SR. (1 Apr 2009). Investigation of Structure-Activity Relationships of Oxyntomodulin (Oxm) Using Oxm Analogs. ENDOCRINOLOGY. 150:1712-1721. Author weblink DOI.
• Druce MR; Bharwani N; Akker SA; Chew SL; Drake WM; Rockall A; Grossman AB. (1 Apr 2009). Intra-abdominal fibrosis in a modern cohort of patients with mid-gut carcinoid tumours - a cross-sectional survey from one centre. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 39:19-19. Author weblink.
• Chaudhri OB; Parkinson JR; Kuo YT; Druce MR; Herlihy AH; Bell JD; Dhillo WS; Stanley SA; et alGhatei MA; Bloom SR. (17 Nov 2006). Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. Biochem Biophys Res Commun. 350:298-306. DOI.
• Druce MR; Bloom SR. (2006). Oxyntomodulin : a novel potential treatment for obesity. Treat Endocrinol. 5:265-272.
• Druce MR; Neary NM; Small CJ; Milton J; Monteiro M; Patterson M; Ghatei MA; Bloom SR. (Feb 2006). Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obes (Lond). 30:293-296. DOI.
• Neary NM; Druce MR; Small CJ; Bloom SR. (Jan 2006). Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut. 55:135.
• Druce MR; Small CJ; Bloom SR. (Jun 2004). Minireview: Gut peptides regulating satiety. Endocrinology. 145:2660-2665. DOI.
• Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; et alCoombes RC; Bloom SR. (Jun 2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 89:2832-2836. DOI.
• Druce MR; Wren AM; Park AJ; Milton JE; Patterson M; Frost G; Ghatei MA; Small C; et alBloom SR. (Sep 2005). Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 29:1130-1136. DOI.
• Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; et alWang F; Kent AS; Frost GS; Ghatei MA; Bloom SR. (Dec 2005). Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology. 146:5120-5127. DOI.